Dynamics of anti-M antibody response in a mouse model following intranasal infection with group A Streptococcus M-18

Journal of Medical Microbiology

Volumn 54, Issue 3, 2005, Pages 305-308

  Gladstone, Paul ^a   Varghese, George ^b   Brahmadathan, K N ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN; PROTEIN ANTIBODY; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; IMMUNOLOGY; MICROBIOLOGY; NOSE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; NOSE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 14544274171     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45555-0     Document Type: Article

References (25)

1. Babu, G. P., Saraswathi, N. P. & John, T. J. (1992). T-lymphocyte mediated injury of B cells in dual aetiology of diabetes mellitus in Swiss albino mouse. Indian J Exp Biol 30, 769-774.
2. Bessen, D. & Fischetti, M. A. (1990). Synthetic peptide vaccine against mucosal colonization by group A streptococci. 1. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 145, 1251-1256.
3. Bradley, A. (2002). Mining the mouse genome. Nature 420, 512-514.
4. Cunningham, M. (2000). Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470-511.
5. Dale, J. B., Simmons, M., Chiang, E. C. & Chiang, E. Y. (1996). Recombinant octavalent group A streptococcal M protein vaccine. Vaccine 14, 944-948.
6. Dale, J. B., Chiang, E. Y., Liu, S., Courtney, H. S. & Hasty, D. L. (1999). New protective antigen of group A streptococci. J Clun Invest 103, 1261-1268.
7. Fischetti, V. A. & Bessen, D. (1998). Effect of mucosal antibodies to M protein on colonization by group A streptococci. In Molecular Mechanisms of Microbial Adhesion, pp. 128-142. New York, NY: Springer.
8. Hall, M. A., Stroop, S. D., Hu, M. C., Walls, M. A., Reddish, M. A., Burt, D. S., Lowell, G. H. & Dale, J. B. (2004). Intranasal immunization with multivalent group A streptococcal vaccine protects mice against intranasal challenge infections. Infect Immun 72, 2507-2512.
9. Harrell, W. K., Ashworth, K., Britt, L. E., Gorge, J. R., Gray, S. B., Green, J. H., Gross, H. & Johnson, J. E. (1982). Preparation of antisera for M types of groups A streptococci. In Procedure Manual for Production of Bacterial, Fungal and Parasitic Reagent, pp. 63-64. Atlanta, GA: Microbiological Reagents Unit, Centers for Disease Control & Prevention.
10. Holm, S. E. (1996). Invasive group A streptococcal infections. N Engl J Med 335, 590-591.
11. Huber, S. A. & Cunningham, M. W. (1996). Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackie viral myocarditis. J Immunol 156, 3528-3534.
12. Jebamani, S., Alice, K., Jeyachand, J., Chandi, S. M., Krishnaswami, S. & Brahmadathan, K. N. (1998). Pharyngeal colonization, ADNB response and development of cardiac lesions following intranasal inoculation with group A beta haemolytic streptococcus M type 18. Indian J Exp Biol 36, 292-297.
13. Jebamani, S., Kuruvilla, A., Chandi, S., Krishnaswami, S. & Brahmadathan, K. N. (1999). Effects of intranasal challenge with group A beta haemolytic streptococcus M type 49 in Swiss albino mice. Indian J Exp Biol 37, 971-975.
14. Ji, Y., Carlson, B., Kondagunta, A. & Cleary, P. (1997). Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococci. Infect Immun 65, 2080-2087.
15. Jones, K. F. & Fischetti, V. A. (1988). The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococcus. J Exp Med 167, 1114-1123.
16. Kaplan, E. L. (1991). The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 10, 55-57.
17. Koshi, G., Benjamin, V. & Cherian, G. (1981). Rheumatic fever and rheumatic heart disease in rural South Indian children. Bull World Health Organ 59, 599-603.
18. Kotloff, K. L., Corretti, M., Palmer, K., Campbell, J. D., Reddish, M. A., Hu, M. C., Wasserman, S. S. & Dale, J. B. (2004). Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial. JAMA 292, 709-715.
19. Medaglini, D., Pozzi, G., King, T. P. & Fischetti, V. A. (1995). Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci 92, 6868-6872.
20. Padmavathi, S. (1995). Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J 47, 395-398.
21. Padmavathi, S. (2001). Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J 53, 35-37.
22. Pozzi, G., Oggioni, M. R., Manganelli, R. & Fischetti, V. A. (1992). Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Res Microbiol 143, 449-457.
23. Smoot, J. C., Barbian, K. D., Van Gompel, J. J. & 15 other authors (2002). Genome sequence and comparative microarray analysis of serotype M 18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A 99, 4668-4673.
24. Veasy, L. G., Tani, L. Y., Daly, J. A., Korgenski, K., Miner, L., Bale, J., Kaplan, E. L., Musser, J. M. & Hill, H. R. (2004). Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113, e168-e172.
25. Wannamaker, L. W. (1970). Differences between streptococcal infections of the throat and of the skin. N Engl J Med 282, 23-31.